Lawsuit Overview
An investor, who currently holds shares of Kite Pharma Inc (NASDAQ:KITE), filed a lawsuit in effort to halt the proposed takeover of Kite Pharma Inc. by Gilead Sciences, Inc. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:KITE investors stockholders by agreeing to sell Kite Pharma Inc. On August 28, 2017, Gilead Sciences, Inc. (Nasdaq: GILD)...
You must register (for free) or login to view the entire case.